Sign in

CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company

Damora Therapeutics, Inc.

Sign in to watch
Ticker
DMRA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
371957007
Phone
(781) 281-9020
Business address
100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
Former names
Galecto, Inc., Galecto Inc.
  1. 4 Open-market buy Director bought 733,333 shares at $15.00 ($10,999,995)
  2. 4 Open-market buy Director bought 66,666 shares at $15.00 ($999,990)
  3. 4 Open-market buy 10% owner bought 333,333 shares at $15.00 ($4,999,995)
  4. 8-K Event Bylaws or fiscal year change
  5. S-8 Other Securities Offered to Employees in Benefit Plans
  6. 424B4 Offering Prospectus
  7. EFFECT Other Notice of Effectiveness
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 3 Insider Initial Statement of Ownership
  11. 3 Insider Initial Statement of Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. CERT Other Certification

Page 17 of 18 · 353 filings